The Department of Defense (DoD) is offering this grant, the Therapeutic Idea Award, to foster the development of new ideas in their early stages, specifically aimed at novel therapeutics for Amyotrophic Lateral Sclerosis (ALS) treatment. This grant is for supporting conceptually innovative, high-risk/high-reward research that holds the potential to yield highly impactful data and open new avenues of investigation. Its primary purpose is to lead to critical discoveries or major advancements in ALS therapeutics. Applicants should propose research projects with a well-formulated, testable hypothesis grounded in strong scientific rationale, ultimately driving forward the understanding and treatment of ALS.
Opportunity ID: 53732
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-10-ALSRP-TIA |
| Funding Opportunity Title: | DoD Amyotrophic Lateral Sclerosis Therapeutic Idea Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 3 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Apr 14, 2010 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Aug 04, 2010 |
| Current Closing Date for Applications: | Aug 04, 2010 |
| Archive Date: | Sep 03, 2010 |
| Estimated Total Program Funding: | $1,920,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | The Therapeutic Idea Award is designed to promote new ideas that are still in the early stages of development with the potential to yield highly impactful data and new avenues of investigation for novel therapeutics for ALS treatment. This mechanism supports conceptually innovative, high-risk/high-reward research that could ultimately lead to critical discoveries or major advancement in ALS therapeutics. Research projects should include a well-formulated, testable hypothesis based on strong scientific rationale. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil
eReceipt HELP: 301-682-5507; help@cdmrp.org Email:cdmrp.pa@amedd.army.mil |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 53732 Full Announcement-1 -> fy10 cdmrp detailed budget and justification form-1.pdf
Folder 53732 Full Announcement-1 -> fy10 cdmrp biosketch-2.pdf
Folder 53732 Full Announcement-1 -> alsrp_fy10 tia pa_gg.pdf
Packages
| Agency Contact Information: | PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil eReceipt HELP: 301-682-5507; help@cdmrp.org Email: cdmrp.pa@amedd.army.mil |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.420 | PKG00017997 | Apr 14, 2010 | Aug 04, 2010 | View |
Package 1
Mandatory forms
53732 RR_SF424_1_2-1.2.pdf
53732 PerformanceSite_1_4-1.4.pdf
53732 RR_KeyPersonExpanded_1_2-1.2.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
